• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Anna Xu at SuperReturn 2023: HIKE Capital Invests in Visionary Founders to Pioneer Future Innovation

    9/25/23 2:39:00 AM ET
    $LI
    $RLX
    Auto Manufacturing
    Industrials
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $LI alert in real time by email

    SINGAPORE, Sept. 25, 2023 /PRNewswire/ -- Challenges in the global macroeconomic and political climate have not deterred HIKE Capital, a leading founders' fund in China, from continuing to invest in innovative Chinese companies with the potential to shape the future.

    (PRNewsfoto/HIKE Capital)

    "We believe that Chinese entrepreneurs have the resilience to weather these cycles and develop top-notch technologies and products to shake up the world in the next digital wave," said Anna Xu, founder of HIKE Capital, at SuperReturn 2023 in Singapore.

    China's certainties in uncertain times

    China has transitioned from its position as the world's factory to become a global hub for product design and R&D, a remarkable fact that can be attributed in large part to China's talent dividend.

    China's possession of the world's largest pool of scientists and engineers, along with a growing number of college graduates, grants the country a significant competitive advantage in the digital economy.

    Having developed the world's most comprehensive industry system and a highly developed supply chain, China has established a commanding position in the new energy sector, especially in the electric vehicle business.

    HIKE Capital has invested in multiple renowned EV companies, including prominent startup LiAuto (2017), and Megatronix (2019), an autonomous driving frontrunner that has achieved revenue growth of over 400% in the past two years.

    Looking ahead to the next decade, "we can expect groundbreaking innovations in autonomous driving and smart cockpit technology to revolutionize the way we travel," Anna said.

    Innovation drives growth

    China's rapidly expanding digital economy has consistently outpaced GDP growth for 11 consecutive years, reaching 50.2 trillion yuan in 2022.

    The industrial Internet has played a pivotal role in accelerating the digital transformation of manufacturing enterprises, empowering them to introduce groundbreaking products and experiences.

    A prominent example is the rising athleisure brand Halara, another HIKE Capital portfolio company. Through smart factory technology, end-to-end digital circulation, and lean management, Halara has reduced its inventory turnover to just 35 days, outperforming its main competitor Lululemon, whose turnover stands at 110 days.

    Another notable example is the new generation insurance broker Yuanbao. The company excels in customer acquisition, quality control of traffic pools, and cost-risk modeling achieved through its AI-powered matching technology. In less than a year, Yuanbao has already accumulated millions of paying users representing 90% regional coverage across China.

    Partnership to drive digital transformation

    As a Founders Fund, HIKE Capital's core strategy prioritizes the continual exploration of world-class startups and strategic investments, particularly during technological waves.

    Anna emphasized that the fund prioritizes partnerships with top entrepreneurs who possess unwavering faith in the power of technology and are committed to driving digital transformation.

    "This approach enables us to transcend market cycles and stay at the forefront of innovation."

    Leveraging extensive experience and a mature methodology, HIKE Capital stands ready to assist more enterprises to achieve long-term success.

    HIKE – Founders Fund 

    Founded in 2015, HIKE is a prominent technology venture capital firm in China co-founded by Mark Yang, the founder of CARS Group and Ganji.com, and Anna Xu, the founder of NetEase news app.

    HIKE Capital is dedicated to supporting entrepreneurs and driving paradigm shifts in the early stages of their businesses.

    With a team of experienced venture partners, HIKE Capital helps founders overcome growth barriers and connect with essential resources.

    The firm manages both USD and RMB Funds, focusing on investments in transportation/new energy, digitalization of the supply chain, and tech-empowered industries.

    HIKE Capital has a successful track record of investing in unicorn companies such as Li Auto (NASDAQ:LI, HKEX:2015))), RELX (NYSE:RLX), CARS Group, Megatronix, Orienspace, Halara, Yuanbao Insurance, FlashEx, Spark Group, Fenbi (HKEX:2469), Yuanfudao, OnQuality, Xbiome, Artivila, etc.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/anna-xu-at-superreturn-2023-hike-capital-invests-in-visionary-founders-to-pioneer-future-innovation-301937208.html

    SOURCE HIKE Capital

    Get the next $LI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LI
    $RLX

    CompanyDatePrice TargetRatingAnalyst
    Li Auto Inc.
    $LI
    3/17/2026$19.00Buy → Neutral
    Goldman
    Li Auto Inc.
    $LI
    2/9/2026$14.00Neutral → Underweight
    Analyst
    Li Auto Inc.
    $LI
    1/23/2026$17.50Buy → Hold
    Jefferies
    Li Auto Inc.
    $LI
    12/4/2025$18.60Buy → Hold
    HSBC Securities
    Li Auto Inc.
    $LI
    12/1/2025$18.50Buy → Hold
    China Renaissance
    Li Auto Inc.
    $LI
    11/11/2025$19.00Neutral
    Piper Sandler
    Li Auto Inc.
    $LI
    9/3/2025$30.50Outperform → Buy
    Daiwa Securities
    Li Auto Inc.
    $LI
    8/28/2025$26.00Buy → Neutral
    BofA Securities
    More analyst ratings

    $LI
    $RLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Li Auto downgraded by Goldman with a new price target

    Goldman downgraded Li Auto from Buy to Neutral and set a new price target of $19.00

    3/17/26 7:56:17 AM ET
    $LI
    Auto Manufacturing
    Industrials

    Li Auto downgraded by Analyst with a new price target

    Analyst downgraded Li Auto from Neutral to Underweight and set a new price target of $14.00

    2/9/26 7:00:29 AM ET
    $LI
    Auto Manufacturing
    Industrials

    Li Auto downgraded by Jefferies with a new price target

    Jefferies downgraded Li Auto from Buy to Hold and set a new price target of $17.50

    1/23/26 8:13:46 AM ET
    $LI
    Auto Manufacturing
    Industrials

    $LI
    $RLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Wang Xing claimed ownership of 367,974,877 units of Class A ordinary shares (SEC Form 3)

    3 - Li Auto Inc. (0001791706) (Issuer)

    3/16/26 10:37:59 AM ET
    $LI
    Auto Manufacturing
    Industrials

    $LI
    $RLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    RLX Technology Announces Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results

    SHENZHEN, China, March 13, 2026 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2025. Fourth Quarter 2025 Financial HighlightsNet revenues were RMB1,141.3 million (US$163.2 million) in the fourth quarter of 2025, increasing by 40.3% from RMB813.5 million in the same period of 2024.Gross margin was 31.4% in the fourth quarter of 2025, compared with 27.0% in the same period of 2024.Non-GAAP income from operations[1] was RMB158.1 million (US$22.6 million) in the fourth quarter of 2025, increasing by 37.9% from

    3/13/26 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    Li Auto Inc. Announces Unaudited Fourth Quarter and Full Year 2025 Financial Results

    Quarterly total revenues reached RMB28.8 billion (US$4.1 billion)1Quarterly deliveries were 109,194 vehiclesFull year total revenues reached RMB112.3 billion (US$16.1 billion)Full year deliveries were 406,343 vehicles BEIJING, China, March 12, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced its unaudited financial results for the quarter and full year ended December 31, 2025. Operating Highlights for the Fourth Quarter of 2025 and Full Year 2025 Total deliveries for the fourth quarter of 2025 were 109,194 vehicles, representing a 31.2% year-over-year decrease.              FY 2025

    3/12/26 4:30:00 AM ET
    $LI
    Auto Manufacturing
    Industrials

    RLX Technology to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 13, 2026

    - Earnings Call Scheduled for 8:00 a.m. ET on March 13, 2026 -SHENZHEN, China, March 3, 2026 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025, before the U.S. markets open on Friday, March 13, 2026. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on March 13, 2026 (8:00 PM Beijing/Hong Kong Time on March 13, 2026).Dial-in details for the earnings conference call are as follows:United States (toll free):+1-888-317-6003International:+1-412-317-60

    3/3/26 3:00:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    $LI
    $RLX
    SEC Filings

    View All

    SEC Form 6-K filed by RLX Technology Inc.

    6-K - RLX Technology Inc. (0001828365) (Filer)

    3/13/26 6:41:30 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Li Auto Inc.

    6-K - Li Auto Inc. (0001791706) (Filer)

    3/12/26 9:26:14 AM ET
    $LI
    Auto Manufacturing
    Industrials

    SEC Form 6-K filed by Li Auto Inc.

    6-K - Li Auto Inc. (0001791706) (Filer)

    3/2/26 7:07:28 AM ET
    $LI
    Auto Manufacturing
    Industrials

    $LI
    $RLX
    Financials

    Live finance-specific insights

    View All

    RLX Technology Announces Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results

    SHENZHEN, China, March 13, 2026 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2025. Fourth Quarter 2025 Financial HighlightsNet revenues were RMB1,141.3 million (US$163.2 million) in the fourth quarter of 2025, increasing by 40.3% from RMB813.5 million in the same period of 2024.Gross margin was 31.4% in the fourth quarter of 2025, compared with 27.0% in the same period of 2024.Non-GAAP income from operations[1] was RMB158.1 million (US$22.6 million) in the fourth quarter of 2025, increasing by 37.9% from

    3/13/26 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    Li Auto Inc. Announces Unaudited Fourth Quarter and Full Year 2025 Financial Results

    Quarterly total revenues reached RMB28.8 billion (US$4.1 billion)1Quarterly deliveries were 109,194 vehiclesFull year total revenues reached RMB112.3 billion (US$16.1 billion)Full year deliveries were 406,343 vehicles BEIJING, China, March 12, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced its unaudited financial results for the quarter and full year ended December 31, 2025. Operating Highlights for the Fourth Quarter of 2025 and Full Year 2025 Total deliveries for the fourth quarter of 2025 were 109,194 vehicles, representing a 31.2% year-over-year decrease.              FY 2025

    3/12/26 4:30:00 AM ET
    $LI
    Auto Manufacturing
    Industrials

    RLX Technology to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 13, 2026

    - Earnings Call Scheduled for 8:00 a.m. ET on March 13, 2026 -SHENZHEN, China, March 3, 2026 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025, before the U.S. markets open on Friday, March 13, 2026. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on March 13, 2026 (8:00 PM Beijing/Hong Kong Time on March 13, 2026).Dial-in details for the earnings conference call are as follows:United States (toll free):+1-888-317-6003International:+1-412-317-60

    3/3/26 3:00:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    $LI
    $RLX
    Leadership Updates

    Live Leadership Updates

    View All

    Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

    The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics, today announced the successful completion of a $42 million Series A financing. The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors including Yuanbio Venture Capital, Legend Capital and C&D Eme

    11/28/24 8:06:00 AM ET
    $BZ
    $HUYA
    $LI
    Computer Software: Programming Data Processing
    Technology
    Auto Manufacturing
    Industrials

    $LI
    $RLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

    SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

    2/7/24 6:06:29 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

    SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

    2/6/24 4:01:28 PM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

    SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

    2/14/23 6:01:42 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care